Expense ratios, yield, and portfolio composition reveal distinct approaches in these defense ETFs—how do their strategies stack up for risk and sector focus?
Canadian investors should understand the TFSA fine print on U.S. stocks, dividends, and withholding taxes to avoid surprises and optimize their account choices.
Corbus Pharmaceuticals (NASDAQ:CRBP) executives and oncology specialists used an ASCO-linked discussion to outline the rationale for focusing the company’s CRB-701 program on recurrent or metastatic oropharyngeal head and neck cancer, particularly in patients whose disease is associated with human p
